Cystic fibrosis transmembrane conductance receptor modulator therapy in cystic fibrosis, an update.
Sign Up to like & getrecommendations! Published in 2020 at "Current Opinion in Pediatrics"
DOI: 10.1097/mop.0000000000000892
Abstract: PURPOSE OF REVIEW Cystic fibrosis transmembrane conductance receptor (CFTR) modulators are a new class of drugs that treat the underlying cause of cystic fibrosis. To date, there are four approved medications, which are mutation-specific. Although… read more here.
Keywords: modulator therapy; cystic fibrosis; fibrosis; cftr modulators ... See more keywords
Prenatal cystic fibrosis transmembrane conductance regulator modulator therapy: A promising way to change the impact of cystic fibrosis.
Sign Up to like & getrecommendations! Published in 2023 at "Fetal diagnosis and therapy"
DOI: 10.1159/000530261
Abstract: INTRODUCTION Cystic fibrosis (CF) is a potentially severe disease. The development of new therapies with cystic fibrosis transmembrane conductance regulator (CFTR) modulators has been a great advance in the management of this condition because they… read more here.
Keywords: fibrosis transmembrane; modulator therapy; fibrosis; cystic fibrosis ... See more keywords